AVTR · NYSE
Avantor, Inc.
$16.97 -0.19 (-1.11%)
Company overview
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NYSE
- Market cap
- $11.5B
- Employees
- 13,500
- Headquarters
- Radnor, PA
- Website
- avantorsciences.com
- CEO
- Emmanuel Ligner
- Listed
- May 17, 2019
- P/E
- -21.16
- Dividend yield
- 0.00%
Company financials
- Revenue
- $6.6B
- Gross profit
- $2.1B
- Operating income
- -$279M
- EBITDA
- $131M
- Net income
- -$551M
- EPS
- -$0.80
- Total assets
- $11.7B
- Total debt
- $37M
- Gross margin
- 32.13%
- Net margin
- -8.42%
- Earnings yield
- -4.73%
Showing FY 2025
AVTR
1D
NYSE
O17.29H17.39L17.07C17.16-0.13 (-0.78%)Vol2.81M